R&D structure close to overseas customers
First written in FY2016. 23 of 25 entries say "Restated". Latest entry: FY2026.
21 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「At the end of the current consolidated fiscal year, the research and development staff totaled 46, and total research and development expenditure for the year was ¥493 million.」
Research and development staff increased from 41 in the previous fiscal year to 46, while research and development expenditure increased from ¥381 million to ¥493 million, expanding both the research and development structure near overseas customers and the scale of ongoing research and development investment. - FY2026-H1RestatedAnnual report
「The Group's research and development expenditure during the current interim consolidated accounting period was ¥194 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥194 million for the current interim period. - FY2024RestatedAnnual report
「株式会社野村マイクロ・サイエンス コリア has research and development functions and is developing a research and development structure closer to major overseas users, seeking to resolve the research challenges requested by users while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain its South Korean base as a research and development center near overseas customers. Research and development staff totaled 37, and total research and development expenditure reached ¥341 million. - FY2024-Q3RestatedAnnual report
「The Group's research and development expenditure during the current third-quarter consolidated cumulative period was ¥245 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed research and development expenditure of ¥245 million for the current third-quarter cumulative period. - FY2023RestatedAnnual report
「株式会社野村マイクロ・サイエンス コリア has research and development functions and is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by users while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain its South Korean base as a research and development center near overseas customers. It has 36 research and development staff, and total research and development expenditure is ¥256 million. - FY2023-Q2RestatedAnnual report
「The group's total research and development expenditure for the first half of the current consolidated cumulative period was ¥104 million. There were no material changes in the status of the group's research and development activities during the first half of the current consolidated cumulative period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥104 million for the current second-quarter cumulative period. - FY2023-Q1RestatedAnnual report
「The group's total research and development expenditure for the cumulative first quarter of the consolidated fiscal year was ¥44 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the consolidated fiscal year.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥44 million for the current first-quarter cumulative period. - FY2022RestatedAnnual report
「株式会社野村マイクロ・サイエンス コリア has research and development functions and is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by users while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain its South Korean base as a research and development center near overseas customers. - FY2022-Q3RestatedAnnual report
「The Group's research and development expenditure during the current third-quarter consolidated cumulative period was ¥137 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed research and development expenditure of ¥137 million for the current third-quarter cumulative period. - FY2021RestatedAnnual report
「株式会社野村マイクロ・サイエンス コリア has research and development functions and is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by customers while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain its South Korean base as a research and development center near overseas customers. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine months ended the third quarter was ¥124 million. There were no material changes in the status of the Group’s research and development activities during the nine months ended the third quarter.」
The Company stated that there were no material changes in the status of its research and development activities and disclosed research and development expenditure of ¥124 million for the current third-quarter cumulative period. - FY2021-Q1RestatedAnnual report
「The group's research and development expenditure for the first quarter of the consolidated cumulative period was ¥41 million. There were no material changes in the status of the group's research and development activities during the first quarter of the consolidated cumulative period.」
The Company continued its research and development activities and disclosed research and development expenditure of ¥41 million for the current first-quarter cumulative period. There were no material changes in the status of its research and development activities. - FY2020RestatedAnnual report
「株式会社野村マイクロ・サイエンス コリア has research and development functions and is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by customers while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain research and development functions at its South Korean base, where it resolves research challenges and makes proposals close to overseas customers. - FY2020-Q3RestatedAnnual report
「The amount spent on R&D activities across the group during the cumulative third quarter of the current consolidated fiscal year was ¥178 million. There were no material changes in the status of the group’s R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥178 million for the current third-quarter cumulative period. - FY2020-Q2RestatedAnnual report
「The Group's research and development expenditure during the current second-quarter consolidated cumulative period was ¥112 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥112 million for the current second-quarter cumulative period. - FY2019RestatedAnnual report
「In addition to the business described above, 株式会社野村マイクロ・サイエンス コリア took over the research and development functions of 株式会社ＮＡＤ, which it absorbed in an absorption-type merger effective 1 January 2014. It is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by customers while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain research and development functions at its South Korean base, where it resolves research challenges and makes proposals close to overseas customers. - FY2019-Q3RestatedAnnual report
「The Group's research and development expenditure during the current third-quarter consolidated cumulative period was ¥185 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The Company disclosed research and development expenditure of ¥185 million for the current third-quarter cumulative period and stated that there were no material changes in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「The Group's research and development expenditure during the current second-quarter consolidated cumulative period was ¥117 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The Company continued its research and development activities and disclosed research and development expenditure of ¥117 million for the current second-quarter cumulative period. There were no material changes in the status of its research and development activities. - FY2019-Q1RestatedAnnual report
「The Group's research and development expenditure during the current first-quarter consolidated cumulative period was ¥49 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥49 million for the current cumulative quarter. - FY2018RestatedAnnual report
「In addition to the business described above, 株式会社野村マイクロ・サイエンス コリア took over the research and development functions of 株式会社ＮＡＤ, which it absorbed in an absorption-type merger effective 1 January 2014. It is developing a research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by customers while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company continues to maintain research and development functions at its South Korean base, where it resolves research challenges and makes proposals close to overseas customers. - FY2018-Q3RestatedAnnual report
「The Group's research and development expenditure during the current third-quarter consolidated cumulative period was ¥127 million. There were no material changes in the status of the Group's research and development activities during the current third-quarter consolidated cumulative period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥127 million for the current third-quarter cumulative period. - FY2018-Q2RestatedAnnual report
「The Group's research and development expenditure during the current second-quarter consolidated cumulative period was ¥81 million. There were no material changes in the status of the Group's research and development activities during the current second-quarter consolidated cumulative period.」
The Company stated that there were no material changes in its research and development activities and disclosed research and development expenditure of ¥81 million for the current second-quarter cumulative period. - FY2018-Q1RestatedAnnual report
「The Group's research and development expenditure during the current first-quarter consolidated cumulative period was ¥34 million. There were no material changes in the status of the Group's research and development activities during the current first-quarter consolidated cumulative period.」
The Company continued its research and development activities and disclosed research and development expenditure of ¥34 million for the quarter. There were no material changes in the status of its research and development structure. - FY2017RestatedAnnual report
「For the purpose of establishing a research and development structure overseas, resolving research challenges requested by customers, and making proposals that contribute to cost reductions alongside improvements in the Company's technical capabilities, the Company established 株式会社ＮＡＤ in South Korea with research and development functions」
The Company continues to maintain its research and development functions in South Korea, close to overseas customers. - FY2016First statedAnnual report
「The Company is developing its research and development structure closer to major overseas customers, seeking to resolve the research challenges requested by customers while proposing measures that contribute to cost reductions alongside improvements in the Group's technical capabilities.」
The Company has consolidated its research and development functions in South Korea at 野村マイクロ・サイエンス コリア, which has taken over the functions of 株式会社ＮＡＤ following its absorption-type merger.